| 000 | 00860cam a2200277 a 4500 | ||
|---|---|---|---|
| 001 | 2980358 | ||
| 003 | OSt | ||
| 005 | 20190925101614.0 | ||
| 008 | 931008s1993 maua b 001 0 eng c | ||
| 010 | _a 92062597 | ||
| 020 | _a188261500X | ||
| 040 |
_aMoSU-L _cMoSU-L _dDLC |
||
| 042 | _alcnccp | ||
| 043 | _an-us--- | ||
| 050 | 0 | 0 |
_aKF3894.B5 _bB56 1993 |
| 082 | 0 | 0 |
_a353.0077/84 _220 |
| 245 | 0 | 0 |
_aBiologics development : _ba regulatory overview / _cedited by Mark Mathieu. |
| 260 |
_aWaltham, MA : _bPAREXEL International Corp., _cc1993. |
||
| 300 |
_aix, 310 p. : _bill. ; _c24 cm. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 0 |
_aBiologicals _zLaw and legislation _xUnited States. |
|
| 700 | 1 | _aMathieu, Mark P. | |
| 906 |
_a7 _bcbc _cnccpada _du _eopcn _f19 _gy-gencatlg |
||
| 942 |
_2lcc _cBK |
||
| 999 |
_c1187 _d1187 |
||